Review compares metformin, OCP for teens with PCOS

Review compares metformin, OCP for teens with PCOS

(HealthDay)—For adolescents with polycystic ovarian syndrome (PCOS), treatment with metformin and oral contraceptive pills can be beneficial, although evidence is limited, according to a review published online April 28 in Pediatrics.

Reem A. Al Khalifah, M.D., from McMaster University in Hamilton, Canada, and colleagues conducted a systematic review and meta-analysis to examine the use of metformin versus oral contraceptive pills for treatment of PCOS in adolescents. Data were included from four (RCTs) with 170 patients.

The researchers found that treatment correlated with a modest improvement in the frequency of menstrual cycle (P < 0.01) and mild reduction of acne scores (P = 0.02). Metformin correlated with a greater body mass index reduction (P < 0.01) and with decreased prevalence of dysglycemia and improved total and levels. In terms of the impact on hirsutism, metformin and oral contraceptive pills were similar.

"Current evidence is derived from very low to low quality evidence. Therefore, treatment choice should be guided by patient values and preferences while balancing potential side effects," the authors write. "Future high quality RCTs are needed to address several questions for the treatment of adolescents with PCOS."

Explore further

Continuous oral contraceptives better after endometriosis Sx

More information: Full Text (subscription or payment may be required)
Journal information: Pediatrics

Copyright © 2016 HealthDay. All rights reserved.

Citation: Review compares metformin, OCP for teens with PCOS (2016, April 28) retrieved 20 September 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more